SCHEMBL4756158

SCHEMBL4756158

COC(=O)c1cccnc1NCCSC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.46
PKM P14618 1/20 0.46
SIRT2 Q8IXJ6 3/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
RAB9A P51151 1/20 0.45
KDM4E B2RXH2 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 3/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42
GLA P06280 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CNR2 P34972 1/20 0.41
BDKRB1 P46663 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4295739 0.90 HTT (0.56) L3MBTL1SIRT2ALDH1A1HPGDRAB9A
SCHEMBL4297348 0.88 SIRT2 (0.49) L3MBTL1PKMSIRT2ALDH1A1HPGD
SCHEMBL4296812 0.87 SIRT2 (0.48) L3MBTL1PKMSIRT2ALDH1A1HPGD
Lithium Ion SCHEMBL4296808 0.85 SIRT2 (0.46) L3MBTL1SIRT2ALDH1A1HPGDRAB9A
SCHEMBL4295736 0.85 SIRT2 (0.43) L3MBTL1SIRT2KIF11
SCHEMBL4756161 0.78 MAPK8 (0.44) SIRT2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL4771680 0.77 KDM4E (0.71) L3MBTL1PKMALDH1A1HPGDRAB9A
SCHEMBL4293392 0.77 SIRT2 (0.47) SIRT2KDM4EKIF11
SCHEMBL4292881 0.76 SIRT2 (0.42) SIRT2ALDH1A1HPGDRAB9AKDM4E
SCHEMBL4288771 0.76 SIRT2 (0.46) SIRT2KDM4EKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896048-A2 PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (PACAP) RECEPTOR (VPAC2) AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE Bayer Pharmaceuticals Corporation (US) 2008-03-12 EP disclosed
WO-2006121588-A2 PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE (PACAP) RECEPTOR (VPAC2) AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE BAYER PHARMACEUTICALS CORPORATION (US) 2006-11-16 WO disclosed